APA (7th ed.) Citation

Rodríguez-Rojas, A., Maciá, M. D., Couce, A., Gómez, C., Castañeda-García, A., Oliver, A., & Blázquez, J. (2010). Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections. PLoS ONE, 5(4), 1. https://doi.org/10.1371/journal.pone.0010193

Chicago Style (17th ed.) Citation

Rodríguez-Rojas, Alexandro, María D. Maciá, Alejandro Couce, Cristina Gómez, Alfredo Castañeda-García, Antonio Oliver, and Jesús Blázquez. "Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. Aeruginosa Infections." PLoS ONE 5, no. 4 (2010): 1. https://doi.org/10.1371/journal.pone.0010193.

MLA (9th ed.) Citation

Rodríguez-Rojas, Alexandro, et al. "Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. Aeruginosa Infections." PLoS ONE, vol. 5, no. 4, 2010, p. 1, https://doi.org/10.1371/journal.pone.0010193.